LBT Half Yearly Report and Accounts 26/02/19 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 31/01/19 PRICE SENSITIVE Share LBT US FDA 510k Submitted for APAS Independence 21/12/18 PRICE SENSITIVE Share LBT LBT Receives $1.9 Million R&D Tax Incentive 20/12/18 PRICE SENSITIVE Share LBT LBT Presentation - 121 Tech Investment Conference, Singapore 03/12/18 PRICE SENSITIVE Share LBT CEO Presentation - AGM 2018 28/11/18 PRICE SENSITIVE Share LBT Chairman's Address to Shareholders 28/11/18 PRICE SENSITIVE Share LBT First Placement of APAS Independence into US Lab 26/11/18 PRICE SENSITIVE Share LBT Australian Sales Update 26/11/18 PRICE SENSITIVE Share LBT Quarterly Activities & Cashflow Report - Appendix 4C 31/10/18 PRICE SENSITIVE Share LBT Company Presentation - Australian Non Deal Roadshow 17/09/18 PRICE SENSITIVE Share LBT Preliminary Final Report 30/08/18 PRICE SENSITIVE Share LBT Finalisation of SA Government Loan Facility Agreement 28/08/18 PRICE SENSITIVE Share LBT First Commercial Sale of APAS Independence 22/08/18 PRICE SENSITIVE Share LBT Quarterly Activities & Cash Flow Report - Appendix 4C 30/07/18 PRICE SENSITIVE Share LBT Market Update 29/06/18 PRICE SENSITIVE download Created with Sketch. 47.64KB Share LBT Strategic Plan & Asset Review, WoundVue 06/06/18 PRICE SENSITIVE download Created with Sketch. 166.01KB Share LBT Quarterly Activities & Cash Flow Report - Appendix 4C 26/04/18 PRICE SENSITIVE Share LBT First Placement of APAS Independence into European Lab 24/04/18 PRICE SENSITIVE Share LBT Share Purchase Plan Offer Document 14/03/18 PRICE SENSITIVE Share LBT $7m Oversubscribed Private Placement & Launch of $1m SPP 06/03/18 PRICE SENSITIVE Share LBT Trading Halt 02/03/18 PRICE SENSITIVE Share LBT Half Yearly Report and Accounts 26/02/18 PRICE SENSITIVE Share LBT LBT Receives $4m Funding from South Australian Government 19/02/18 PRICE SENSITIVE Share LBT Quarterly Activities & Cash Flow Report (Appendix 4C) 29/01/18 PRICE SENSITIVE Share LBT $2.5M Grant Awarded to Advance WoundVue Development 07/12/17 PRICE SENSITIVE Share LBT Completion of Transaction with Autobio 01/12/17 PRICE SENSITIVE Share LBT St Vincent's Hospital Completes APAS Independence Evaluation 29/11/17 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 31/10/17 PRICE SENSITIVE Share LBT Autobio $2M Placement in LBT & MicroStreak IP Transfer 27/10/17 PRICE SENSITIVE Share LBT LBT Receives $4.2 Million in R&D Incentives 09/10/17 PRICE SENSITIVE Share LBT ST Vincent's Hospital Commences APAS Automated Evaluation 27/09/17 PRICE SENSITIVE Share LBT Preliminary Final Report 31/08/17 PRICE SENSITIVE Share LBT LBT's WoundVue Prototype to be used at CALHN 08/08/17 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 10/07/17 PRICE SENSITIVE Share LBT CE Mark Self Certification Finalised for APAS 23/06/17 PRICE SENSITIVE Share LBT ST VINCENTS HOSPITAL MELBOURNE TO BE FIRST APAS TRIAL SITE 21/06/17 PRICE SENSITIVE Share LBT LBT Appointed Distributor for Australia and New Zealand 14/06/17 PRICE SENSITIVE Share LBT Share Purchase Plan Offer 23/05/17 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 26/04/17 PRICE SENSITIVE Share LBT APAS INCLUDED ON THE AUSTRALIAN TGA REGISTER 28/03/17 PRICE SENSITIVE Share LBT Half Yearly Report and Accounts 27/02/17 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 31/01/17 PRICE SENSITIVE Share LBT Completion of Placement 02/12/16 PRICE SENSITIVE Share LBT Trading Halt 30/11/16 PRICE SENSITIVE Share LBT LBT Innovations Granted New Patent for United States 11/11/16 PRICE SENSITIVE Share LBT Appendix 4C - quarterly-LBT.AX 27/10/16 PRICE SENSITIVE Share LBT US FDA GRANTS APPROVAL FOR APAS-LBT.AX 10/10/16 PRICE SENSITIVE Share LBT Preliminary Final Report-LBT.AX 31/08/16 PRICE SENSITIVE Share LBT Appendix 4C - quarterly-LBT.AX 29/07/16 PRICE SENSITIVE Share LBT LBT granted patent in Japan for core APAS technology-LBT.AX 19/05/16 PRICE SENSITIVE Share LBT Cochlear Executive Brent Barnes Appointed CEO of LBT-LBT.AX 09/05/16 PRICE SENSITIVE Share LBT Appendix 4C - quarterly-LBT.AX 26/04/16 PRICE SENSITIVE Share LBT LBT Receives Notice of Allowance for Third Patent-LBT.AX 07/04/16 PRICE SENSITIVE Share LBT Half Yearly Report and Accounts 29/02/16 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 29/01/16 PRICE SENSITIVE Share LBT LBT Innovations Completes U.S. Regulatory Submission 22/12/15 PRICE SENSITIVE Share LBT LBT Concludes APAS Clinical Trial Program 16/11/15 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 20/10/15 PRICE SENSITIVE Share LBT LBT Receives Notice of Allowance for Second Patent 14/10/15 PRICE SENSITIVE Share LBT LBT CEO Retirement 12/10/15 PRICE SENSITIVE Share LBT APAS Exceeds Expectations in Key U.S. Clinical Trials 07/10/15 PRICE SENSITIVE Share LBT LBT Innovations Market Update 28/08/15 PRICE SENSITIVE Share LBT Preliminary Final Report 27/08/15 PRICE SENSITIVE Share LBT LBT Signs Agreement with bioMerieux 27/08/15 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 31/07/15 PRICE SENSITIVE Share LBT LBT begins key U.S. trial of APAS technology 09/06/15 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 28/04/15 PRICE SENSITIVE Share LBT LBT Granted First U.S. Patent for APAS Technology 26/03/15 PRICE SENSITIVE Share LBT Appendix 4D 27/02/15 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 30/01/15 PRICE SENSITIVE Share LBT Notice of Intent re PREVI Isola Licence Agreement 12/01/15 PRICE SENSITIVE Share LBT LBT Completes Australian Clinical Trials of APAS Technology 26/11/14 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 24/10/14 PRICE SENSITIVE Share LBT LBT Awarded $250,000 Grant for Woundvue 20/10/14 PRICE SENSITIVE Share LBT LBT Begins Clinical Trials of APAS Technology 19/09/14 PRICE SENSITIVE Share LBT LBT Innovations receives $3M 2014 R&D tax incentive 04/09/14 PRICE SENSITIVE Share LBT Appendix 4E 29/08/14 PRICE SENSITIVE Share LBT Appendix 4C - quarterly report 31/07/14 PRICE SENSITIVE Share LBT LBT raises A$1.5M in private placement 18/06/14 PRICE SENSITIVE Share LBT Trading Halt 16/06/14 PRICE SENSITIVE Share LBT LBT Innovations receives third $1M milestone payment 11/06/14 PRICE SENSITIVE Share LBT LBT Innovations Introduces Landmark Diagnostic Platform 12/05/14 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 28/04/14 PRICE SENSITIVE Share LBT Response to Price Query 10/04/14 PRICE SENSITIVE Share LBT Appendix 4D Half Year Results 20/02/14 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 31/01/14 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 17/10/13 PRICE SENSITIVE Share LBT Preliminary Final Report 21/08/13 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 26/07/13 PRICE SENSITIVE Share LBT LBT wins grant for APAS development 03/07/13 PRICE SENSITIVE Share LBT Profit Guidance 02/07/13 PRICE SENSITIVE Share LBT LBT Innovations Finalises Joint Venture 25/06/13 PRICE SENSITIVE Share LBT Trading Halt 21/06/13 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 17/04/13 PRICE SENSITIVE Share LBT LBT enters into exclusive discussions 15/04/13 PRICE SENSITIVE Share LBT Appendix 4D Half Year Results 27/02/13 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 25/01/13 PRICE SENSITIVE Share LBT Earnings Guidance 14/12/12 PRICE SENSITIVE Share LBT Appendix 4C - quarterly 24/10/12 PRICE SENSITIVE Share
(20min delay)
